NOV 19, 2019 8:21 PM PST

Experimental Cholesterol-Lowering Drug

WRITTEN BY: Nouran Amin

A recent study shows that patients who take a maximum dose of statin drugs in addition to a twice-yearly injection of the experimental cholesterol-lowering drug, inclisiran, was effective at reducing low-density lipoprotein (LDL) cholesterol, often called bad cholesterol. Results of the study were generated from the ORION-10, a phase 3 placebo-controlled, double-blind, randomized clinical trial.

Learn more about LDL cholesterol:

 

 

When increased levels of LDL cholesterol builds up in the walls of the arteries, blood cannot pass through efficiently which leads to blockage. This blockage, as a result of hard and narrow capillaries, puts a patient at risk of heart attacks and strokes. "Maintaining low LDL over a sustained period is essential to reduce the risk of heart attacks and stroke," says R. Scott Wright, M.D., a Mayo Clinic cardiologist and principal investigator of ORION-10 trial.

Inclisiran is the only siRNA drug that works to lower cholesterol. Developed by the Medicines Company, the drug works to mimic a gene variant and prevent the production of the protein PCSK9, this in turn lowers LDL.

"The data show that inclisiran dosed twice-yearly achieved durable and potent LDL reductions with an excellent safety profile, and no treatment-related liver or kidney side effects," Dr. Wright says. "Twice-yearly administration by a health care professional coincides with typical patient visits, which can help with medication adherence."

Source: Science Daily

About the Author
BS/MS
Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
APR 16, 2022
Neuroscience
A New Approach to Seizure Treatment
APR 16, 2022
A New Approach to Seizure Treatment
There are many types of epilepsy, a brain disorder that causes recurrent seizures or periods of altered behaviors or sen ...
APR 22, 2022
Health & Medicine
Differences in the Impact of Acute and Chronic Cannabis Use on Stress Response Regulation
APR 22, 2022
Differences in the Impact of Acute and Chronic Cannabis Use on Stress Response Regulation
A new study published in Frontiers examined the influence of acute and chronic cannabis use on stress regulation. Althou ...
MAY 13, 2022
Health & Medicine
Increased Mental Health Risks Linked to High Potency Cannabis Concentrates
MAY 13, 2022
Increased Mental Health Risks Linked to High Potency Cannabis Concentrates
As more states legalize cannabis for medical and recreational purposes, the association between excessive cannabis consu ...
MAY 23, 2022
Drug Discovery & Development
A Possible Therapy for Infantile Spasms
MAY 23, 2022
A Possible Therapy for Infantile Spasms
Researchers at Texas Children’s Hospital have identified a possible cause of infantile spasms (IS) as well as a po ...
MAY 31, 2022
Drug Discovery & Development
Computer Models Help Find Antibiotics to Fight Drug-Resistant Pathogens
MAY 31, 2022
Computer Models Help Find Antibiotics to Fight Drug-Resistant Pathogens
Antibiotics were a revolutionary tool in the fight against bacterial infections. In recent years, however, the emergence ...
JUN 16, 2022
Cancer
Dance/Movement Therapy Benefits Cancer Patients
JUN 16, 2022
Dance/Movement Therapy Benefits Cancer Patients
For cancer treatment, standard of care (sometimes referred to as best practice or standard therapy) defines medical trea ...
Loading Comments...